Antimicrobial therapy in German Shepherd dog pyoderma (GSP). An open clinical study

Twenty-five pure-bred and two cross-bred German Shepherd dogs with German Shepherd dog pyoderma (GSP) were treated with enrofloxacin as an antimicrobial therapy. Following 28 weeks of treatment at a dose rate of 5 mg kg(-1), administered orally once daily, excellent results were obtained in 23 dogs (85.2%), and fair results in three dogs (11.1%). One dog (3.7%) showed no response. These findings indicate that enrofloxacin therapy is an effective antimicrobial treatment for the bacterial infection in GSP.